CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,825,000 | -31.6% | 1,250,000 | -24.2% | 4.91% | -32.9% |
| Q2 2023 | $53,823,000 | +22.4% | 1,650,000 | +32.0% | 7.32% | +16.3% |
| Q1 2023 | $43,987,500 | -36.0% | 1,250,000 | -16.7% | 6.30% | -21.8% |
| Q4 2022 | $68,730,000 | -16.6% | 1,500,000 | -11.8% | 8.05% | -20.5% |
| Q3 2022 | $82,365,000 | +19.8% | 1,700,000 | -2.9% | 10.13% | -19.7% |
| Q2 2022 | $68,758,000 | +15.7% | 1,750,000 | +8.4% | 12.62% | +63.7% |
| Q1 2022 | $59,448,000 | -1.6% | 1,615,000 | +21.9% | 7.71% | +23.7% |
| Q4 2021 | $60,394,000 | +69.0% | 1,325,000 | +32.5% | 6.23% | +141.7% |
| Q3 2021 | $35,740,000 | +29.0% | 1,000,000 | -28.6% | 2.58% | +10.7% |
| Q2 2021 | $27,706,000 | +70.2% | 1,400,000 | +100.0% | 2.33% | +46.5% |
| Q1 2021 | $16,282,000 | +0.3% | 700,000 | -6.7% | 1.59% | -23.5% |
| Q3 2020 | $16,238,000 | -13.9% | 750,000 | -6.2% | 2.08% | -44.9% |
| Q2 2020 | $18,856,000 | +728.1% | 800,000 | +314.2% | 3.77% | +335.1% |
| Q1 2020 | $2,277,000 | – | 193,129 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |